NCT01343953已完成2 期
A Prospective Phase II Study to Evaluate Cord Blood Transplantation in Inherited or Acquired Severe Aplastic Anemia Refractory or in Relapse After Immunosuppressive Therapy
适应症
干预措施
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 26
- 试验地点
- 1
- 主要终点
- Overall survival
研究概览
简要总结
This is a Prospective Phase II Study to evaluate Cord Blood Transplantation in Inherited or Acquired Severe Aplastic Anemia Refractory or in Relapse after Immunosuppressive Therapy in the absence of an HLA identical donor;
详细描述
This is a Prospective Phase II Study to evaluate Cord Blood Transplantation in Inherited or Acquired Severe Aplastic Anemia Refractory or in Relapse after Immunosuppressive Therapy in the absence of an Human Leucocyte Antigen (HLA) identical donor; 26 patients will be recruited, according to a one step Fleming design
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 3 Years 至 55 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age: 3-55 years old
- •inherited aplastic anemia (with severe aplastic anemia criteria) or acquired aplastic anemia in relapse or treatment failure after immunosuppressive therapy without clonal evolution
- •Karnovsky Index >= 60%
- •Informed consent
排除标准
- •HLA identical donor
研究组 & 干预措施
Cord Blood Transplantation
Experimental
干预措施: Cord Blood Transplantation (Procedure)
结局指标
主要结局
Overall survival
时间窗: 1 year
次要结局
- karnofsky scale(1 year)
- Infectious episodes(1 year)
- treatment related mortality(100 days)
- overall survival(5 years)
- adverse events(1 year)
- Graft versus host disease(2 years)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Safety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients With Hematologic MalignanciesAcute Myelogenous LeukemiaChronic Myelogenous LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic SyndromeNCT00270881Keio University33
已完成
1 期
Phase I Study of Sequential Cord Blood TransplantsMultiple MyelomaLymphomaLeukemiaMyelodysplastic SyndromeNCT00299767Massachusetts General Hospital21
已完成
2 期
Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic CancerRecurrent Plasma Cell MyelomaRefractory Chronic Myelogenous LeukemiaRefractory Follicular LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Mantle Cell LymphomaRecurrent Marginal Zone LymphomaRecurrent T-Cell Non-Hodgkin LymphomaRecurrent Lymphoplasmacytic LymphomaMyeloproliferative NeoplasmRefractory Hodgkin LymphomaRefractory Lymphoplasmacytic LymphomaRefractory Mantle Cell LymphomaRefractory Small Lymphocytic LymphomaT-Cell Non-Hodgkin LymphomaAggressive Non-Hodgkin LymphomaIndolent Non-Hodgkin LymphomaRecurrent Follicular LymphomaRecurrent Small Lymphocytic LymphomaRefractory Chronic Lymphocytic LeukemiaChronic Phase Chronic Myelogenous LeukemiaChronic Myelogenous LeukemiaMixed Phenotype Acute LeukemiaLymphomaAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic SyndromeNCT00723099Fred Hutchinson Cancer Center73
已完成
2 期
Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic DiseaseNon-Hodgkin LymphomaProlymphocytic LeukemiaAcute Biphenotypic LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 PositiveChronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveLymphoplasmacytic LymphomaMyelodysplastic SyndromeMantle Cell LymphomaRefractory AnemiaLymphoblastic LymphomaSmall Lymphocytic LymphomaBurkitt LymphomaMarginal Zone LymphomaFollicular LymphomaPlasma Cell MyelomaMyelofibrosisAcute Myeloid LeukemiaChronic Lymphocytic LeukemiaAcute Lymphoblastic LeukemiaNCT00719888Fred Hutchinson Cancer Center135
已完成
2 期
Trial Of Double Umbilical Cord Blood TransplantationHematological MalignanciesNCT00763490University of Michigan Rogel Cancer Center20